The FDA approved the first Alzheimer’s drug in nearly 20 years. The agency’s decision drew controversy following warnings from independent advisers on the treatment known as Aduhelm. Dr. Jon LaPook has more. Source

JOIN NCOV.LINK NEWSLETTER

And get notified everytime we publish a new Important announcements. We will not email you often, unless there are important things that need to get in touch with you, such as added new tools or new domain names.